Status:
COMPLETED
AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CareDx
Conditions:
Kidney Transplant Failure and Rejection
Eligibility:
All Genders
18-75 years
Brief Summary
This is a prospective cohort observational study to assess the role of AlloSure Donor Derived Cell Free DNA (ddcfDNA) assay in the monitoring of three high-risk groups of kidney transplant patients fo...
Detailed Description
This is a prospective cohort observational study to assess the role of AlloSure Donor Derived Cell Free DNA (ddcfDNA) assay in the monitoring of three high-risk groups of patients for antibody mediate...
Eligibility Criteria
Inclusion
- Kidney transplant recipients (de novo or retransplant)
- Positive Virtual Crossmatch at transplant (Group A)
- Undergoing SOC biopsy for dnDSA (Group B)
- Proven cAMR (Group C)
Exclusion
- Multi-Visceral transplant
- Contraindication to renal biopsy
Key Trial Info
Start Date :
October 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 7 2024
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04057742
Start Date
October 7 2019
End Date
April 7 2024
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin - Madison
Madison, Wisconsin, United States, 53705